Reasons and Risk Factors For Discontinuation of Treatment with Any Biological Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis: A Long-term Observational Study.

Kenya TerabeNobunori TakahashiShuji AsaiYuji HiranoYasuhide KanayamaYuichiro YabeTakeshi OguchiTakayoshi FujibayashiHisato IshikawaMasahiro HanabayashiYosuke HattoriMochihito SuzukiKenji KishimotoYoshifumi OhashiTakahiro ImaizumiShiro ImagamaToshihisa Kojima

Published in: Modern rheumatology (2022)

Older patients are at higher risk of discontinuing bDMARDs treatment due to AEs than younger patients.

Keyphrases

end stage renal disease
rheumatoid arthritis
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
replacement therapy
drug induced